VOLUNTARY ANNOUNCEMENT STRATEGIC COOPERATION AGREEMENT WITH A SUBSIDIARY OF CR SANJIUStrategic Cooperation Agreement • June 29th, 2022
Contract Type FiledJune 29th, 2022This announcement is made by ClouDr Group Limited (the “Company”, together with its subsidiaries and consolidated affiliated entities, the “Group”) on a voluntary basis. The board of directors (the “Directors”) of the Company (the “Board”) is pleased to announce that the Company entered into a non-legally binding strategic cooperation agreement (the “Strategic Cooperation Agreement”) with 昆明華潤聖火藥業有限公司 (China Resources Kunming Shenghuo Pharmaceutical Co., Ltd.*) (“CR Shenghuo”), a wholly-owned subsidiary of 華潤三九醫藥股份有限公司 (China Resources Sanjiu Medical & Pharmaceutical Co., Ltd.*) (“CR Sanjiu”), on March 5, 2024.